Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SRDX - SURMODICS INC


IEX Last Trade
39.525
0.010   0.025%

Share volume: 2,740
Last Updated: Fri 27 Dec 2024 08:25:32 PM CET
Surgical and Medical Instrument Manufacturing : -0.06%

PREVIOUS CLOSE
CHG
CHG%

$39.52
0.01
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
32%
Profitability 39%
Dept financing 33%
Liquidity 50%
Performance 20%
Company vs Stock growth
vs
Performance
5 Days
0.38%
1 Month
0.33%
3 Months
3.07%
6 Months
-5.48%
1 Year
7.19%
2 Year
24.87%
Key data
Stock price
$39.52
P/E Ratio 
-404.15
DAY RANGE
$39.25 - $39.52
EPS 
-$0.10
52 WEEK RANGE
$25.87 - $42.43
52 WEEK CHANGE
$9.13
MARKET CAP 
565.401 M
YIELD 
N/A
SHARES OUTSTANDING 
14.267 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
0.58
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$148,511
AVERAGE 30 VOLUME 
$163,856
Company detail
CEO: Gary R. Maharaj
Region: US
Website: surmodics.com
Employees: 450
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Surmodics, Inc. provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices. The IVD segment designs, develops, and manufactures component products and technologies for diagnostics. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Recent news